Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | hypocretin (orexin) receptor 2 | Starlite/ChEMBL | References |
Homo sapiens | hypocretin (orexin) receptor 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma japonicum | ko:K04209 neuropeptide Y receptor, invertebrate, putative | Get druggable targets OG5_127863 | All targets in OG5_127863 |
Schistosoma mansoni | neuropeptide receptor | Get druggable targets OG5_127863 | All targets in OG5_127863 |
Echinococcus multilocularis | G protein coupled receptor 139 | Get druggable targets OG5_127863 | All targets in OG5_127863 |
Echinococcus multilocularis | neuropeptide receptor | Get druggable targets OG5_127863 | All targets in OG5_127863 |
Echinococcus granulosus | neuropeptide receptor | Get druggable targets OG5_127863 | All targets in OG5_127863 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Echinococcus granulosus | sex peptide receptor | hypocretin (orexin) receptor 1 | 425 aa | 350 aa | 23.4 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Trichomonas vaginalis | dexras1, putative | 0.0066 | 0.4462 | 0.5 |
Echinococcus multilocularis | G protein coupled receptor 139 | 0.0128 | 1 | 1 |
Onchocerca volvulus | Bile acid receptor homolog | 0.0016 | 0 | 0.5 |
Trichomonas vaginalis | ras-dva small GTPase, putative | 0.0066 | 0.4462 | 0.5 |
Trichomonas vaginalis | ral, putative | 0.0066 | 0.4462 | 0.5 |
Entamoeba histolytica | ras-1, putative | 0.0066 | 0.4462 | 0.5 |
Brugia malayi | Ras protein let-60 | 0.0066 | 0.4462 | 1 |
Entamoeba histolytica | Ras family GTPase | 0.0066 | 0.4462 | 0.5 |
Schistosoma mansoni | neuropeptide receptor | 0.0128 | 1 | 1 |
Onchocerca volvulus | 0.0016 | 0 | 0.5 | |
Trichomonas vaginalis | rheb, putative | 0.0066 | 0.4462 | 0.5 |
Trichomonas vaginalis | rap1 and, putative | 0.0066 | 0.4462 | 0.5 |
Brugia malayi | Ras-related protein R-Ras2 | 0.0066 | 0.4462 | 1 |
Trichomonas vaginalis | GTP-binding protein rit, putative | 0.0066 | 0.4462 | 0.5 |
Echinococcus multilocularis | ras gtpase | 0.0066 | 0.4462 | 0.4462 |
Onchocerca volvulus | Steroid hormone receptor family member cnr14 homolog | 0.0016 | 0 | 0.5 |
Echinococcus granulosus | ras gtpase | 0.0066 | 0.4462 | 0.4462 |
Entamoeba histolytica | Ras family GTPase | 0.0066 | 0.4462 | 0.5 |
Onchocerca volvulus | Protein ultraspiracle homolog | 0.0016 | 0 | 0.5 |
Echinococcus multilocularis | neuropeptide receptor | 0.0128 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.4462 | 1 |
Loa Loa (eye worm) | Ras protein let-60 | 0.0066 | 0.4462 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Kd (binding) | = 196 nM | BindingDB_Patents: Radioligand Binding Assay . Radioligand binding assay using orexin receptor. | ChEMBL. | No reference |
Kd (binding) | = 205 nM | BindingDB_Patents: Radioligand Binding Assay. Radioligand binding assay using orexin receptor. | ChEMBL. | No reference |
Ki (binding) | = 6.56 | Antagonist activity at human OX1 receptor expressed in CHO cells assessed as inhibition of orexin A-induced Ca2+ accumulation after 1 hr by Fluo-4-AM staining-based FLIPR assay | ChEMBL. | 23964859 |
Ki (binding) | = 7.16 | Antagonist activity at human OX2 receptor expressed in HEK cells assessed as inhibition of orexin A-induced Ca2+ accumulation after 1 hr by Fluo-4-AM staining-based FLIPR assay | ChEMBL. | 23964859 |
Ki (binding) | = 47 nM | BindingDB_Patents: FLIPR Assay . FLIPR assay using orexin receptor. | ChEMBL. | No reference |
Ki (binding) | = 236 nM | BindingDB_Patents: FLIPR Assay. FLIPR assay using orexin receptor. | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.